Kintara Therapeutics, Inc.
KTRA
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.32M | -9.33M | -10.58M | -13.02M | -14.65M |
| Total Depreciation and Amortization | 55.00K | 53.00K | 60.00K | 60.00K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 798.00K | 1.99M | 3.40M | 4.70M | 4.92M |
| Change in Net Operating Assets | 291.00K | 43.00K | 360.00K | 1.45M | -2.19M |
| Cash from Operations | -7.18M | -7.24M | -6.77M | -6.81M | -11.87M |
| Capital Expenditure | -20.00K | -20.00K | -20.00K | 0.00 | -232.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -20.00K | -20.00K | -20.00K | 0.00 | -232.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10.58M | 10.62M | 2.62M | 43.00K | 1.95M |
| Repurchase of Common Stock | -- | -- | -- | -48.00K | -48.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.00K | -8.00K | -8.00K | -8.00K | -8.00K |
| Other Financing Activities | -- | -43.00K | -43.00K | -43.00K | -43.00K |
| Cash from Financing | 10.57M | 10.57M | 2.57M | -56.00K | 1.85M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.37M | 3.31M | -4.22M | -6.87M | -10.25M |
